Trust in the global leader in MST and Spectral Shift with over 15 years of experience with Nanotemper Technologies.
Explore the Crelux fully integrated services for early stage drug discovery to measure affinities like no screen has done before:
Cover more chemical space, screen, profile and find hits faster than ever!
Boost your project now and discover new dimensions of biophysical affinity screening with our Dianthus Spectral Shift service.
Measure 1,000,000 compounds in 2 weeks. For starters.
Never before has compound screening been this fast at this scale.
With over 500 protein targets successfully screened, we are the global experts in biophysics and high-throughput screening.
We generate your optimized proteins for biophysical assays, ensuring both speed and precision.
Our high-throughput approach at reduced material consumption significantly accelerates your drug discovery process.
“Since 2011, Crelux has been more than a partner — they’ve been a forward-thinking collaborator, consistently among the first to adopt our latest technologies. Most notably, their early adoption of Spectral Shift set a benchmark in applying next-generation biophysical tools to real-world applications. Their deep expertise in custom protein production and biophysical analysis has been instrumental in driving scientific progress. Our long-standing relationship is built on trust, innovation, and a shared commitment to advancing drug discovery.”
For over two decades, Crelux, a WuXi AppTec company, has provided collaborative programs and specialized services in early-stage drug discovery for clients from the pharmaceutical, biotech and chemical industries as well as to academic and research institutions.
Our platform covers all services required to support your early-stage drug discovery projects, from protein production and biophysical characterization through to structural biology, biochemistry, cellular assays, medicinal chemistry and project management. Together we take you from gene to hit to structure, tailored to your needs!
Novalix 2025: Unleashing the Power of Spectral Shift Technology for Ultra-High-Throughput Binding Assays
Combining Ready-To-Go Assays with Dianthus Spectral Shift Technology to Accelerate the Discovery of CRBN-DDB1 Proteolysis-Targeting Chimeras and Molecular Glues
Let's talk! Arrange a call with our experts and find out how Spectral Shift technology can accelerate your drug discovery. Call us (+49-89-7007600) or simply fill out the form below and we will get back to you shortly.
You will receive an email from us shortly, in which you will be asked to kindly confirm the appointment.
A second email will contain the invitation and the following attachments:
We look forward to helping you succeed in your drug discovery journey!
While you wait: check out our our catalogue of ready-to-go services for even faster turnaround times.